The IL1RN gene helps make a natural brake on inflammation, the immune response behind redness, swelling, pain, and fever. If this gene does not work properly, inflammation can become too strong and, in rare cases, cause an early-onset condition with skin, joint, and bone problems. This gene plays an important role in keeping immune signals balanced. Most people only hear about IL1RN during genetic testing or evaluation for unusual inflammatory symptoms.
What is a gene?
A gene is a section of DNA that gives your cells instructions they can use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, which are the parts of cells that do the work. Other genes mainly control when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medicines. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
IL1RNGene function
What if the gene works
The IL1RN gene makes a protein that blocks one of the body's main inflammation signals. This helps keep inflammation more controlled and limits tissue irritation after infection or injury.
Risk
What if the gene does not work
More disruptive variants in the IL1RN gene can cause a rare inflammatory condition, often starting in infancy, with skin and bone inflammation. Milder variants may leave some activity, which can affect when symptoms begin and how severe they are.
Treatment
What does that mean for your treatment
Pathogenic loss-of-function variants in the IL1RN gene make IL-1 blocking treatment central to care. Anakinra is the most established choice because it replaces the missing natural brake on IL-1, a key inflammation signal. If anakinra cannot be used, other IL-1 blockers such as canakinumab may help in some cases.
Conditions associated with IL1RN
Gene function
What if the gene works
Your immune system needs clear stop signals so inflammation settles at the right time. The IL1RN gene helps provide one of those signals by making a protein that blocks certain inflammatory messages. This explains what the IL1RN gene does in the body during everyday immune responses.
One of the main roles of the IL1RN gene is to make a natural protein that puts the brakes on inflammation. It helps keep normal immune signals from lasting longer or becoming stronger than needed.
Its protein sits on the interleukin 1 receptor, the cell’s docking site for inflammatory messages, without turning it on. This blocks two strong inflammatory messenger proteins, IL-1α and IL-1β, from sending their usual signal.
When the IL1RN gene works properly, inflammation can rise to deal with infection or injury and then settle in a more controlled way. This helps protect nearby tissues, such as joints and skin, from unnecessary irritation.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IL1RN gene can reduce or eliminate the interleukin-1 receptor antagonist protein. Some change its shape or stability, so less protein is released from cells or it cannot block its target well. Others, including more disruptive variants, stop the protein from being made at all. This explains how IL1RN gene variants affect protein function, and more complete loss is linked to earlier and more severe inflammation.
How variants are linked to conditions
Pathogenic variants in the IL1RN gene cause deficiency of the interleukin-1 receptor antagonist, a rare inherited autoinflammatory condition. Babies with this diagnosis often develop widespread skin and bone inflammation soon after birth, and doctors may also find fever and high inflammation markers on blood tests. In contrast, some common IL1RN variants have been studied for links to inflammatory diseases such as rheumatoid arthritis or inflammatory bowel disease, but these findings do not by themselves diagnose a condition.
A variant is not necessarily a diagnosis
Gene variants are a routine feature of human biology and are widespread in the general population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definitive diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For IL1RN, risk is mainly shaped by inherited gene changes rather than lifestyle. A child is most likely to be affected when both parents carry a harmful IL1RN change, and this is more common in families with a known history of the condition or where the parents are biologically related.
Inheritance of IL1RN variants
For families asking about the IL1RN inheritance pattern, disease-causing variants in the IL1RN gene are inherited in an autosomal recessive way. This means a child usually needs to inherit two altered copies, one from each parent, to have IL1RN-related disease. Parents who each carry one variant are usually unaffected carriers, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a carrier child, and a 25% chance of having a child without the familial variants. Because IL1RN is on chromosome 2, it can be passed to children of any sex.
What does my IL1RN result mean for my family?
For families with an IL1RN-related condition, it is usually passed down in a recessive pattern. This often means parents are healthy carriers, while brothers and sisters may also be affected or may be carriers. Close relatives may also carry the same gene change, especially in families with more than one affected child.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the IL1RN gene, IL1RN genetic testing uses a blood sample, saliva, or a cheek swab. A lab reads the gene’s DNA and checks for variants that may help confirm a diagnosis or explain symptoms. Results are interpreted alongside your medical history and family history.
When should I consider getting a genetic test?
Testing for IL1RN may be worth considering when a baby or young child has severe unexplained inflammation, especially with a pus-filled skin rash, bone pain or swelling, or a family history of this rare condition. A positive result can help confirm the cause and guide treatment.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies based on the condition and the kind of variant involved. Lifestyle, environment, age, and medical history, along with other factors, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that helps one person may work less well in another, or may cause more side effects, because the body absorbs, breaks down, or responds to the drug differently. These differences are common and are one reason medication response is not the same for everyone. In some cases, genetics helps explain why a person is more sensitive to a medicine or why a standard treatment has a smaller effect.
What is Pharmacogenetics?
Pharmacogenetics studies how differences in genes can shape a person’s response to medications. It examines gene drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the IL1RN gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose, so general questions about symptoms, treatment, or side effects are best discussed with your doctor. IL1RN has been studied for links to response to some anti-inflammatory treatments, but the findings are not consistent enough to guide routine care.
History
In the 1980s, researchers studying inflammation identified a natural substance that could block the effects of interleukin 1, a major step in cytokine research. This work led to the cloning of the IL1RN gene and showed that the body makes its own brake on inflammatory signals. Building on this early work, scientists uncovered more about the gene and used that knowledge to develop anakinra, a medicine based on the same pathway. Interest in the IL1RN gene grew further when rare inherited variants were linked to a severe inflammatory condition in infants, helping connect basic research with patient care. These discoveries made IL1RN an important part of the modern history of inflammation research and targeted treatment.